LYELL IMMUNOPHARMA INC

CUSIP: 55083R104 Class: Common Stock

UBS Group AG's Holding History (CIK: 0001610520)

Note: Option positions (PUT/CALL) are excluded.

Q1 2025
Shares 110,401 Value ($000) $59 Avg Close — Range —
Q4 2024
Shares 864,287 Value ($000) $553 Avg Close — Range —
Q3 2024
Shares 108,713 Value ($000) $150 Avg Close — Range —
Q2 2024
Shares 84,813 Value ($000) $123 Avg Close — Range —
Q1 2024
Shares 199,178 Value ($000) $444 Avg Close — Range —
Q4 2023
Shares 218,840 Value ($000) $425 Avg Close — Range —
Q3 2023
Shares 195,076 Value ($000) $287 Avg Close — Range —
Q2 2023
Shares 153,178 Value ($000) $487 Avg Close — Range —
Q1 2023
Shares 221,283 Value ($000) $522 Avg Close — Range —
Q4 2022
Shares 411,026 Value ($000) $1,426 Avg Close — Range —
Q3 2022
Shares 20,318 Value ($000) $149 Avg Close — Range —
Q2 2022
Shares 5,218 Value ($000) $34 Avg Close — Range —
Q1 2022
Shares 5,000 Value ($000) $25 Avg Close — Range —
Q4 2021
Shares 14,408 Value ($000) $112 Avg Close — Range —
Q3 2021
Shares 268 Value ($000) $4 Avg Close — Range —